相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Standardization and Cross Validation of Alloreactive IFN ELISPOT Assays Within the Clinical Trials in Organ Transplantation Consortium
I. Ashoor et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Pretransplant Interferon- Secretion by CMV-Specific CD8+T Cells Informs the Risk of CMV Replication After Transplantation
S. Cantisan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Pretransplant Immediately Early-1-Specific T Cell Responses Provide Protection for CMV Infection After Kidney Transplantation
O. Bestard et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Cross-Validation of IFN- Elispot Assay for Measuring Alloreactive Memory/Effector T Cell Responses in Renal Transplant Recipients
O. Bestard et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation
Emily Blyth et al.
BLOOD (2013)
Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study
Oriol Manuel et al.
CLINICAL INFECTIOUS DISEASES (2013)
Comparison of Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot and CMV Quantiferon Gamma Interferon-Releasing Assays in Assessing Risk of CMV Infection in Kidney Transplant Recipients
Davide Abate et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Impaired Direct Priming of CD8 T Cells by Donor-Derived Cytomegalovirus Following Kidney Transplantation
Shazia Shabir et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
High Incidence of Anticytomegalovirus Drug Resistance Among D plus R- Kidney Transplant Recipients Receiving Preemptive Therapy
L. Couzi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy
S. F. Atabani et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
State-of-the-Art Monitoring of Cytomegalovirus-Specific Cell-Mediated Immunity After Organ Transplant: A Primer for the Clinician
Adrian Egli et al.
CLINICAL INFECTIOUS DISEASES (2012)
Human Cytomegalovirus-Specific T-Cell Immune Reconstitution in Preemptively Treated Heart Transplant Recipients Identifies Subjects at Critical Risk for Infection
Davide Abate et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Importance of the cytomegalovirus seropositive recipient as a contributor to disease burden after solid organ transplantation
Vincent C. Emery et al.
JOURNAL OF CLINICAL VIROLOGY (2012)
Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia
Luiz F. Lisboa et al.
TRANSPLANTATION (2012)
Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: 1-Year Results of a Randomized Clinical Trial
Oliver Witzke et al.
TRANSPLANTATION (2012)
Paradoxical Aspects of Rapamycin Immunobiology in Transplantation
I. R. Ferrer et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Virologic and Immunologic Monitoring of Cytomegalovirus to Guide Preemptive Therapy in Solid-Organ Transplantation
G. Gerna et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Cytomegalovirus Incidence Between Everolimus Versus Mycophenolate in De Novo Renal Transplants: Pooled Analysis of Three Clinical Trials
D. C. Brennan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections
Emilia Genini et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
Primary Cytomegalovirus Phosphoprotein 65-Specific CD8+ T-Cell Responses and T-bet Levels Predict Immune Control During Early Chronic Infection in Lung Transplant Recipients
Matthew R. Pipeling et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
A. Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study
Fredrik Sund et al.
CLINICAL TRANSPLANTATION (2010)
Strategies for managing cytomegalovirus in transplant recipients
Raymund R. Razonable
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Evaluation of Cytomegalovirus (CMV)-Specific T Cell Immune Reconstitution Revealed That Baseline Antiviral Immunity, Prophylaxis, or Preemptive Therapy but not Antithymocyte Globulin Treatment Contribute to CMV-Specific T Cell Reconstitution in Kidney Transplant Recipients
Davide Abate et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Rapamycin-Resistant mTORC1 Kinase Activity Is Required for Herpesvirus Replication
Nathaniel J. Moorman et al.
JOURNAL OF VIROLOGY (2010)
Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study
Henrik Ekberg et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+and CD8+T cells in kidney allograft recipients at risk of CMV infection
Albert J. Eid et al.
TRANSPLANT INTERNATIONAL (2010)
International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation
Camille N. Kotton et al.
TRANSPLANTATION (2010)
Prolonged Prophylaxis With Valganciclovir Is Cost Effective in Reducing Posttransplant Cytomegalovirus Disease Within the United States
Emily A. Blumberg et al.
TRANSPLANTATION (2010)
Monitoring Cytomegalovirus T-Cell Immunity in Small Bowel/Multivisceral Transplant Recipients
A. Chiereghin et al.
TRANSPLANTATION PROCEEDINGS (2010)
Quantiferon-CMV Test in Prediction of Cytomegalovirus Infection After Kidney Transplantation
A. Lochmanova et al.
TRANSPLANTATION PROCEEDINGS (2010)
Adoptive T-Cell Therapy of a Lung Transplanted Patient with Severe CMV Disease and Resistance to Antiviral Therapy
G. Brestrich et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Cell-Mediated Immunity to Predict Cytomegalovirus Disease in High-Risk Solid Organ Transplant Recipients
D. Kumar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
Carson C. Thoreen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Six-Month Prophylaxis Is Cost Effective in Transplant Patients at High Risk for Cytomegalovirus Infection
Fu L. Luan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
mTOR regulates memory CD8 T-cell differentiation
Koichi Araki et al.
NATURE (2009)
High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function
Peter Nickel et al.
TRANSPLANT IMMUNOLOGY (2009)
The number of activating KIR genes inversely correlates with the rate of CMV infection/reactivation in kidney transplant recipients
M. Stern et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation
F. M. Mattes et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Natural Killer Cell Receptor Repertoire and Their Ligands, and the Risk of CMV Infection After Kidney Transplantation
K. Hadaya et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: Results of a randomized clinical trial
V. Kliem et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Linking CMV serostatus to episodes of CMV reactivation following lung transplantation by measuring CMV-specific CD8+ T-cell immunity
G. P. Westall et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation
Rafael San Juan et al.
CLINICAL INFECTIOUS DISEASES (2008)
Investigation of promoter variations in dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN) (CD209) and their relevance for human cytomegalovirus reactivation and disease after allogeneic stem-cell transplantation
M. Mezger et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients
Adrian Egli et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
Inconsistent responses of cytomegalovirus-specific T cells to pp65 and IE-1 versus infected dendritic cells in organ transplant recipients
D. Lilleri et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Relationship between toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation
Supha Kijpittayarit et al.
CLINICAL INFECTIOUS DISEASES (2007)
Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV disease
Corinna La Rosa et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Association between mannose-binding lectin deficiency and cytomegalovirus infection after kidney transplantation
Oriol Manuel et al.
TRANSPLANTATION (2007)
Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation
Joseph P. Casazza et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Monitoring of human cytomegalovirus-specific CD4+ and CD8+ T-cell immunity in patients receiving solid organ transplantation
G. Gerna et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients
J. A. Khoury et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Antiviral drugs for cytomegalovirus in transplant recipients: advantages of preemptive therapy
Nina Singh
REVIEWS IN MEDICAL VIROLOGY (2006)
Meta-analysis: The efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients
AC Kalil et al.
ANNALS OF INTERNAL MEDICINE (2005)
Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects
AW Sylwester et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials
EM Hodson et al.
LANCET (2005)
Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation
U Sester et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting
MF Pahl-Seibert et al.
JOURNAL OF VIROLOGY (2005)
Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients
A Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells
T Bunde et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Canadian Society of Transplantation Consensus Workshop on Cytomegalovirus Management in solid organ transplantation final report
JK Preiksaitis et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Contemporaneous fluctuations in T cell responses to persistent herpes virus infections
T Crough et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Cellular immune responses to cytomegalovirus in renal transplant recipients
R Radha et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Properties of CD4+ T cells in human cytomegalovirus infection
LE Gamadia et al.
HUMAN IMMUNOLOGY (2004)
Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation
J Hjelmesæth et al.
DIABETOLOGIA (2004)
Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection
TJ Manley et al.
BLOOD (2004)
Innate sensing of viruses by toll-like receptors
KW Boehme et al.
JOURNAL OF VIROLOGY (2004)
Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival
S Sagedal et al.
KIDNEY INTERNATIONAL (2004)
Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H
R Elkington et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers
R Elkington et al.
JOURNAL OF VIROLOGY (2003)
Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2
T Compton et al.
JOURNAL OF VIROLOGY (2003)
Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection
M Sester et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients
S Sagedal et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2002)
Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation
M Sester et al.
TRANSPLANTATION (2001)
Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8+ T lymphocytes in healthy seropositive donors
GMA Gillespie et al.
JOURNAL OF VIROLOGY (2000)
分享论文
